Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

计划入组 25 人 · 首次发布于 2024 年 10 月 18 日

FA Clinical Outcome Measures

计划入组 2,000 人 · 首次发布于 2017 年 3 月 27 日

NAD+ and Exercise in FA

计划入组 75 人 · 首次发布于 2019 年 12 月 10 日

FA-87

FA-70

FA-613

LYOPHILIZATION SERVICES OF NEW ENGLAND, INC.

United States

Jadavpur University

India

BETASPACE ETF UNITS

United States

First-Ever Clinical Trial Launches to Test Afatinib in Fanconi Anemia-Associated Head and Neck Cancer

PTC Therapeutics Plans FDA Submission for Vatiquinone in Friedreich's Ataxia

OncoPrism-HNSCC RNA Test Shows Improved Prediction of Immunotherapy Response in Head and Neck Cancer